US3666800A - Substituted triiodoisophthalamic acids - Google Patents
Substituted triiodoisophthalamic acids Download PDFInfo
- Publication number
- US3666800A US3666800A US47886A US3666800DA US3666800A US 3666800 A US3666800 A US 3666800A US 47886 A US47886 A US 47886A US 3666800D A US3666800D A US 3666800DA US 3666800 A US3666800 A US 3666800A
- Authority
- US
- United States
- Prior art keywords
- acid
- triiodo
- methylisophthalamic
- ethyl
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
Definitions
- the present invention relates to new compounds of the formula and to basic salts of these compounds, e.g., alkali metal salts such as, for example, sodium and potassium; alkaline earth salts such as, for example, calcium; ammonium salts such as, for example, N-methylglucamine, as well as lower aliphatic esters of up to 6 carbon atoms such as methyl, ethyl, propyl, ipropyl, n-butyl, i-butyl, n-pentyl, 2-methylbutyl, neopentyl, nhexyl, 2-methylpentyl, 3-methylpentyl, 2,2-dimethylbutyl and 2 ,3-dimethylbutyl esters.
- the R and R. are hydrogen or an alkyl radical of up to six carbon atoms and R is an alkyl radical of up to six carbon atoms.
- the new compounds of the present invention include the following compounds as well as the above-mentioned basic salts and aliphatic esters thereof:
- the reaction is carried out in an inert solvent such as ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, dimethylformarnide, dimethylacetamide, tetrahydrofuran, dimethylsulfoxide and the like.
- an inert solvent such as ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, dimethylformarnide, dimethylacetamide, tetrahydrofuran, dimethylsulfoxide and the like.
- a hydrogen chloride acceptor such as pyridine, N-methylmorpholine, triethyl-amine, etc., in which case the hydrogen chloride acceptor may also be used as the solvent, if desired.
- the starting materials of formula II in which R is hydrogen are readily obtained by the procedure described by Hoey et al. [1. Med. Chem. 6, 24 (1963)].
- the starting materials of formula II in which R is alkyl are obtained by condensing 5- arnino N-substituted-isophthalamic acids with an aldehyde, followed by reduction of the Schiff base thus obtained to the 5-alkylamino-N-substituted-isophthalamic acid.
- the acids are reacted with an inorganic or organic base, e.g., alkali metal hydroxide such as sodium hydroxide, or amines, such as nmethylglucamine.
- an inorganic or organic base e.g., alkali metal hydroxide such as sodium hydroxide, or amines, such as nmethylglucamine.
- the esters may be formed by treating an alkaline solution of a compound offormula l with a di(lower alkyl) sulfate such as dimethyl sulfate or by treatment with a diazoalkane such as diazomethane.
- the salts, especially insoluble salts frequently provide a convenient means of isolating and purifying the product.
- the new products of fonnula l are useful as radiopaque agents for visualization of animal systems or organs, preferably in the fom'l of physiologically acceptable salts such as sodium or methylglucamine salts for the preparation of solutions for intravascular injection for urography and for vasographic techniques such as angiocardiography, arteriography, nephrography and venography.
- physiologically acceptable salts such as sodium or methylglucamine salts
- the water-insoluble esters are useful in visualizing hollow organs and cavities having external orifices through which'the contrast preparation can be introduced in preparation for the examination and removal after the examination is completed.
- the precipitated solid is filtered, washed with dilute hydrochloric acid and dried under reduced pressure at about 100.
- The; 5- (3-methylureido)-2,4,6-triiodo-N-methylisophthalamic acid thus obtained is a white solid melting at about l-l85 with decomposition.
- EXAMPLE 4 S-( 3-Methylureido )-2,4,6-Triiodo-N-Ethylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of -5 -amino-2,4,6-triiodo-N-ethylisophthalamic acid for the 5-amino-2,4,6-triiodoN-methylisophthalamic acid, there is obtained the desired 5-(3- methylureido)-2,4,6-triiodo-N-ethylisophthalamic acid.
- EXAMPLE 6 5-( S-Ethylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid a. Methyl N-Ethyl-N-Methyl-S-Nitroisophthalamate A solution of 55.6 grams of 3-carbomethoxy-5-nitrobenzoyl chloride in 200 ml of carbon tetrachloride is added slowly to a well-stirred mixture of 13.5 grams of ethylmethylamine, 200 ml of water, 50 ml of acetone and 9.3 grams of sodium hydroxide. The carbon tetrachloride and acetone are removed by concentration under reduced pressure.
- the precipitated solid is filtered, washed with water and redissolved in dilute aqueous ammonia.
- the solution is treated with decolorizing carbon, filtered and acidified with dilute hydrochloric acid.
- the precipitate is collected by filtration, washed with water and then recrystallized from aqueous alcohol to yield the desired N-ethyl-N-methyl-S- nitroisophthalamic acid.
- 5-Amino-N-Ethyl-N-Methylisophthalamic Acid A mixture of 12 grams of N-ethyl-N-methyl-S- nitroisophthalamic acid, 1 gram of 5 percent palladium on carbon and l50 ml of methanol is shaken in a Parr hydrogenator under a pressure of 50 lbs/sq.in. of hydrogen. After the theoretical quantity of hydrogen has been absorbed, the mixture is filtered and the catalyst washed thoroughly with methanol. The filtrate and washings are combined and concentrated under reduced pressure to yield the desired 5- amino-N-ethyl-N-methylisophthalamic acid. d.
- EXAMPLE 7 5-( 3 ,3-Dimethylureido )-2,4,6-Triiodo-N- Methylisophthalamic Acid To 3 grams of 5-amino-2,4,6triiodoN-methylisophthalamic acid in 25 ml of anhydrous pyridine there is added dropwise, with vigorous stirring, a solution of 1 gram of dimethylcarbamoyl chloride in l0 ml of anhydrous benzene. The reaction mixture is warmed gently to complete the reaction and then concentrated under reduced pressure to remove the benzene. The residue is poured onto a mixture of ice and 20 percent hydrochloric acid.
- the precipitated solid is filtered, washed with dilute acid, and dried at 100 under reduced pressure to yield the desired 5-(3,3-dirnethyl-ureido)-2,4,6-trii0do-N- methylisophthalamic acid.
- the product may be purified by solution in dilute alkali and reprecipitation with hydrochloric acid.
- EXAMPLE 8 5-( 3-Methyll -n-Propylureido )2,4,6-Triiodo-N- Methylisophthalamic Acid a) 5-nPropylamino-N-Methylisophthalamic Acid To a solution of 9.7 grams of S-amino-N- methylisophthalamic acid in 150 ml of methanol, there is added 4 ml of propionaldehyde and the mixture hydrogenated at room temperature and atmospheric pressure using 4 grams of Raney nickel as catalyst. The catalyst is filtered off, and the filtrate concentrated under reduced pressure to yield the desired 5-n-propylamino-N-methylisophthalamic acid. b.
- EXANIPLE 9 5-( 3 ,B-Dimethyll-n-Propylureido )-2,4,6-Triiodo-N-Methyllsophthalarnic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-n-propylamino-2,4,6-triiodo-N- methylisophthalamic acid for the 5-amino-2,4,6-triiodo-N- methylisophthalamic acid, there is obtained the desired 5- EXAMPLE l 3-Methyll -n-Propylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid a) 5-n-Propylamino-2,4,6Triiodo-N-Ethyl-N- Methylisophthalarnic Acid Following the procedure of Example 8 a,b, but substituting an equivalent amount of S-arnino-N-ethyl
- EXAMPLE 14 a 5-Ethylamino-2,4,6-Triiodoisophtha1amic Acid Following the procedure of Example 8 a,b, but substituting an equivalent amount of S-aminoisophthalamic acid for the 5- amino-N-methylisophthalamic acid and an equivalent amount EXAMPLE l5 5-( l,3,3-Triethylureido)-2,4,6-Triiodoisophthalamic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-ethylamino-2,4,6-triiodoisophthalamic acid for the 5-amino-2,4,6-triiodo-N-methyl-isophthalamic acid and an ealuivalent amount of dieth 'l-carbamoyl chloride ere is obtained the for the dime ylcarbamoyl chloride, desired 5-( l,3,3-triethylureido)-2,4,6-triiodoiso
- EXAMPLE l6 Ethyl 5-( 3-methylureido)-2,4,6-Triiodo-N-Methylisophthalamate To a stirred slurry of 21 grams of 5-( 3-methyl-ureido)-2,4,6 -triiodo-N-methylisophthalamic acid in ml of absolute ethanol, there is added a solution of '2.2 grams of potassium hydroxide in 50 m] of absolute ethanol. To this mixture there is added 4.5 ml of diethyl sulfate. The mixture is allowed to stir overnight and I00 ml of water added. The reaction mixture is concentrated to dryness and suspended in dilute alkali.
- the solution is filtered and the crude ester thus obtained is the desired ethyl 5-( 3-methylureido)-2,4,6-triiodo-N- methylisophthalamate.
- the product may be purified by solution in warm dimethylformamide, treating with decolorizing carbon and dilution of the filtrate with water to precipitate the desired ester.
- R and R are hydrogen or alkyl of up to six carbon atoms and R is alkyl of up to six carbon atoms, as well as lower alkyl esters and physiologically acceptable salts thereof wherein the alkyl ester has up to six carbon atoms.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
WHEREIN R and R2 are hydrogen or alkyl and R'' is alkyl, as well as salts and lower alkyl esters of these compounds are useful as radiopaque agents.
Compounds having the formula
Compounds having the formula
Description
United States Patent Bernstein et a].
[4 1 May 30, 1972 SUBSTITUTED TRIIODOISOPHTHALAMIC ACIDS [72] Inventors: Jack Bernstein; Kathryn Alice Losee, both of New Brunswick, NJ.
[73] Assignee: E. R. Squibb 8: Sons, Inc., New York,
[22] Filed: June 19, 1970 [2]] Appl. No.: 47,886
Fieser, L. F., et a]. Organic Chemistry, 3rd Edit. (1956), pub. by Reinhold Pub. Corp. page. 608 cited.
Primary Examiner-Lorraine A. Weinberger Assistant Examiner-L. Arnold Thaxton Attorney-Lawrence S. Levinson, Merle J. Smith, Donald J. Perrella and Burton Rodney ABSTRACT Compounds having the formula wherein R and R are hydrogen or alkyl and R is alkyl, as well as salts and lower alkyl esters of these compounds are useful as radiopaque agents.
5 Claims, No Drawings OBJECTS OF THE INVENTION It is an object of the present invention to provide new compounds which are useful radiopaque agents. Another object is to provide methods for the preparation of these compounds. These and other objects of the present invention will be ap parent from the following description.
DETAILED DESCRIPTION The present invention relates to new compounds of the formula and to basic salts of these compounds, e.g., alkali metal salts such as, for example, sodium and potassium; alkaline earth salts such as, for example, calcium; ammonium salts such as, for example, N-methylglucamine, as well as lower aliphatic esters of up to 6 carbon atoms such as methyl, ethyl, propyl, ipropyl, n-butyl, i-butyl, n-pentyl, 2-methylbutyl, neopentyl, nhexyl, 2-methylpentyl, 3-methylpentyl, 2,2-dimethylbutyl and 2 ,3-dimethylbutyl esters. In the compounds of the present invention the R and R. are hydrogen or an alkyl radical of up to six carbon atoms and R is an alkyl radical of up to six carbon atoms.
The new compounds of the present invention include the following compounds as well as the above-mentioned basic salts and aliphatic esters thereof:
5-( 3-methylureido )-2,4,o-triiodo-N-methyl-isophthalamic acid 5-(3-n-butylureido)-2,4,6-triiodo-N-methyl-isophthalamic acid 5-( 3-n-hexylureido )-2,4,6-triiodo-N-methyl-isophthalamic acid 5-( 3-methylureido)-2,4,6-triiodo-N-ethyl-isophthalamic acid 5-( 3-methylureido )-2,4,6-triiodo-N,N-dimethylisophthalamic acid 5-( 3-ethylureido )-2,4,6-triiodoN-ethyl-N- methylisophthalamic acid 5-( 3 ,3dimethylureido )-2 ,4 ,6-triiodo-N-methylisophthalamic acid 5-( 3-methyll -n-propylureido)-2,4,6-triiodo-N- methylisophthalamic acid 5-( 3,3-dimethyll -n-propylureido )-2,4,6-triiodo-N- methylisophthalamic acid 5-( 3-methyll -n-propylureido)-2,4,6-triiodo-N-ethyl-N- methylisophthalamic acid 5-( 3,3-dimethyll -n-propylureido )-2,4,6-triiodo-N-ethyl-N- methylisophthalamic acid 5-( 3-n-butylureido)-2,4,6-triiodoisophthalamic acid 5-( 3,3-dimethylureido)-2,4,6-triiodoisophthalamic acid 5-( 3-methyll -ethylureido)-2,4,6-triiodoisophthalamic acid 5-( l,3,3-triethylureido)-2,4,6-triiodoisophthalamic acid The compounds of the present invention may be prepared by the reaction of an appropriately substituted 5-amino-2,4,6- triiodoisophthalamic acid of the formula II 30 OH N m R wherein R and R are as previously defined with an alkyl isocyanate of the formula R'NCO ill or a dialkylcarbamoyl halide of the formula Iv R N-C O-X a- H Rf wherein X is a halogen, preferably chlorine and R is as previously defined.
The reaction is carried out in an inert solvent such as ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, dimethylformarnide, dimethylacetamide, tetrahydrofuran, dimethylsulfoxide and the like. In those cases where a dialkylcarbamoyl chloride is a reactant, it is advantageous to use a hydrogen chloride acceptor, such as pyridine, N-methylmorpholine, triethyl-amine, etc., in which case the hydrogen chloride acceptor may also be used as the solvent, if desired.
The starting materials of formula II in which R is hydrogen are readily obtained by the procedure described by Hoey et al. [1. Med. Chem. 6, 24 (1963)]. The starting materials of formula II in which R is alkyl are obtained by condensing 5- arnino N-substituted-isophthalamic acids with an aldehyde, followed by reduction of the Schiff base thus obtained to the 5-alkylamino-N-substituted-isophthalamic acid.
To prepare salts of the compound .of formula I, the acids are reacted with an inorganic or organic base, e.g., alkali metal hydroxide such as sodium hydroxide, or amines, such as nmethylglucamine. The esters may be formed by treating an alkaline solution of a compound offormula l with a di(lower alkyl) sulfate such as dimethyl sulfate or by treatment with a diazoalkane such as diazomethane. The salts, especially insoluble salts, frequently provide a convenient means of isolating and purifying the product.
The new products of fonnula l are useful as radiopaque agents for visualization of animal systems or organs, preferably in the fom'l of physiologically acceptable salts such as sodium or methylglucamine salts for the preparation of solutions for intravascular injection for urography and for vasographic techniques such as angiocardiography, arteriography, nephrography and venography. The water-insoluble esters are useful in visualizing hollow organs and cavities having external orifices through which'the contrast preparation can be introduced in preparation for the examination and removal after the examination is completed. Solutions having EXAMPLE l 5-( 3Methylureido)-2,4,6-Triiodo-N-Methylisophthalamic Acid To a solution of 1 gram of 5-amino-2,4,6-triiodo-N- methylisophthalamic acid in 100 ml of ethylene glycol dimethyl ether there is added lml of methyl isocyanate and the reaction mixture heated under reflux for 20 hours. The solvent is removed by distillation under reduced pressure and the residue dissolved in dilute sodium hydroxide solution. The solution is treated with decolorizing carbon, filtered and made strongly acid with 10 percent hydrochloric acid. The precipitated solid is filtered, washed with dilute hydrochloric acid and dried under reduced pressure at about 100. The; 5- (3-methylureido)-2,4,6-triiodo-N-methylisophthalamic acid thus obtained is a white solid melting at about l-l85 with decomposition.
EXAMPLE 2 5-(3-n-Butylureido)-2,4,6-Triiodo-N-Methylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of n-butyl' isocyanate for the methyl iso-.
cyanate, there is obtained the desired S-(S-n-butyl-ureido 2,4,fi-triiodo-N-methylisophthalamic acid.
EXAMPLE 3 3-N-Hexylureido )-2 ,4,6-Triiodo-N-Methylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of n-hexyl isocyanate for the methyl isocyanate, there is obtained the desired 5-( 3-n-hexyl-ureido)- 2,4,6-triiodo-N-methylisophthalamic acid.
EXAMPLE 4 S-( 3-Methylureido )-2,4,6-Triiodo-N-Ethylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of -5 -amino-2,4,6-triiodo-N-ethylisophthalamic acid for the 5-amino-2,4,6-triiodoN-methylisophthalamic acid, there is obtained the desired 5-(3- methylureido)-2,4,6-triiodo-N-ethylisophthalamic acid.
EXAMPLE 5 5-(3-Methylureido)-2,4,6-Triiodo-N,N-Dimethylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of S-amino-2,4,6-triiodo-N,N-dimethylisophthalamic acid for the 5-amino-2,4,6 triiodo-N-methylisophthalamic acid, there is obtained the desired 5-(3- methylureido )-2,4,6-triiodo-N,N-dimethylisophthalamic acid.
EXAMPLE 6 5-( S-Ethylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid a. Methyl N-Ethyl-N-Methyl-S-Nitroisophthalamate A solution of 55.6 grams of 3-carbomethoxy-5-nitrobenzoyl chloride in 200 ml of carbon tetrachloride is added slowly to a well-stirred mixture of 13.5 grams of ethylmethylamine, 200 ml of water, 50 ml of acetone and 9.3 grams of sodium hydroxide. The carbon tetrachloride and acetone are removed by concentration under reduced pressure. The residue is cooled and the precipitated methyl N-ethyl-N- methyl-5-nitroisophthalamate separated from the aqueous layer. b. N-Ethyl-N-Methyl-S-Nitroisophthalamic Acid The crude methyl N'ethyl-N-methyl-5-nitroisophthalamate obtained in (a) is dissolved in a minimum amount of alcohol and an equal volume of water is added. Sodium carbonate is added until the pH of the mixture is 8 and the reaction mixture is then heated to reflux with stirring for 1 hour. The mixture is diluted with water, filtered and the filtrate poured into excess hydrochloric acid. The precipitated solid is filtered, washed with water and redissolved in dilute aqueous ammonia. The solution is treated with decolorizing carbon, filtered and acidified with dilute hydrochloric acid. The precipitate is collected by filtration, washed with water and then recrystallized from aqueous alcohol to yield the desired N-ethyl-N-methyl-S- nitroisophthalamic acid. c. 5-Amino-N-Ethyl-N-Methylisophthalamic Acid A mixture of 12 grams of N-ethyl-N-methyl-S- nitroisophthalamic acid, 1 gram of 5 percent palladium on carbon and l50 ml of methanol is shaken in a Parr hydrogenator under a pressure of 50 lbs/sq.in. of hydrogen. After the theoretical quantity of hydrogen has been absorbed, the mixture is filtered and the catalyst washed thoroughly with methanol. The filtrate and washings are combined and concentrated under reduced pressure to yield the desired 5- amino-N-ethyl-N-methylisophthalamic acid. d. 5-Amino-2,4,6-Triiodo-N-Ethyl-N-Methylisophthalamic Acid To a stirred suspension of grams of S-amino-N-ethyl-N- methylisophthalamic acid in 250 ml of water there is added over the course of 1 hour a solution of l6 grams of iodine monochloride and 19 grams of potassium chloride in 150 ml of water. The reaction mixture is stirred for 5 hours after the addition is complete and a solution of 10 grams of sodium hydroxide in 25 ml of water added. To this stirred mixture there is then added a solution of 8 grams of iodine monochloride and 9.5 grams of potassium chloride in 75 ml of water over the course of 1 hour. The 'reaction mixture is stirred for 24 hours and the 5-amino-2,4,6-triiodoN-ethyl-N- methylisophthalarnic acid filtered and washed thoroughly with water. The product may be purified by crystallization of the ammonium salt and conversion of the ammonium salt to the free acid by treatment with hydrochloric acid. e. 5-( 3-Ethylureido )-2,4,6Triiodo-N-Ethyl-N-Methyllsophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of ethyl isocyanate for the methyl isocyanate and an equivalent amount of 5-amino-2,4,6-triiodo- N-ethyl-N-methylisophthalamic acid for the 5-amino-2,4,6- triiodo-N-methylisophthalamic acid, there is obtained the desired 5-( 3-ethylureido )-2,4,6-triiodo-N-ethyl-N- methylisophthalamic acid.
EXAMPLE 7 5-( 3 ,3-Dimethylureido )-2,4,6-Triiodo-N- Methylisophthalamic Acid To 3 grams of 5-amino-2,4,6triiodoN-methylisophthalamic acid in 25 ml of anhydrous pyridine there is added dropwise, with vigorous stirring, a solution of 1 gram of dimethylcarbamoyl chloride in l0 ml of anhydrous benzene. The reaction mixture is warmed gently to complete the reaction and then concentrated under reduced pressure to remove the benzene. The residue is poured onto a mixture of ice and 20 percent hydrochloric acid. The precipitated solid is filtered, washed with dilute acid, and dried at 100 under reduced pressure to yield the desired 5-(3,3-dirnethyl-ureido)-2,4,6-trii0do-N- methylisophthalamic acid. The product may be purified by solution in dilute alkali and reprecipitation with hydrochloric acid.
EXAMPLE 8 5-( 3-Methyll -n-Propylureido )2,4,6-Triiodo-N- Methylisophthalamic Acid a) 5-nPropylamino-N-Methylisophthalamic Acid To a solution of 9.7 grams of S-amino-N- methylisophthalamic acid in 150 ml of methanol, there is added 4 ml of propionaldehyde and the mixture hydrogenated at room temperature and atmospheric pressure using 4 grams of Raney nickel as catalyst. The catalyst is filtered off, and the filtrate concentrated under reduced pressure to yield the desired 5-n-propylamino-N-methylisophthalamic acid. b. 5-n-Propylamino-2,4,6-Triiodo-N-Methylisophthalamic Acid Following the procedure of Example 6d but substituting an equivalent amount of S-n-propylamino-N-methylisophtha]amic acid for the 5-amino-N-ethyl-N-methylisophthalamic acid, there is obtained the desired 5-n-propylamino2,4,6Triiodo- N-methylisophthalamic acid.
EXANIPLE 9 5-( 3 ,B-Dimethyll-n-Propylureido )-2,4,6-Triiodo-N-Methyllsophthalarnic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-n-propylamino-2,4,6-triiodo-N- methylisophthalamic acid for the 5-amino-2,4,6-triiodo-N- methylisophthalamic acid, there is obtained the desired 5- EXAMPLE l 3-Methyll -n-Propylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid a) 5-n-Propylamino-2,4,6Triiodo-N-Ethyl-N- Methylisophthalarnic Acid Following the procedure of Example 8 a,b, but substituting an equivalent amount of S-arnino-N-ethyl-N- methylisophthalamic acid for the S-amino-N- methylisophthalamic acid, there is obtained the desired 5-npropylamino-2,4,6-triiodo-N-ethyl-N-methylisophthalamic acid. b. 5-( 3-Methyl-1-n-Pr0pylureido)-2,4,6-Tiiiodo-N-Ethyl-N- Methylisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount of 5-n-propylamino-2,4,6-triiodo-N-ethyl- N-methylisophthalamic acid for the 5-amino-2,4,6-triiodo-N- methylisophthalamic acid, there is obtained the desired 5-( 3- methyl- 1 n-propylureido )-2.4,6-triiodo-N-ethyl-N- methylisophthalamic acid.
EXAMPLE 1 l 5-( 3 ,3-Dimethyll -n-Propylureido )-2,4,6-Triiodo-N-Ethyl-N- Methylisophthalamic Acid Following the procedure of Example 7 but substituting an equivalent amount of S-n-propylureido-2,4,6-triiodo-N-ethyl- N-methylisophthalamic acid for the 5-amino-2,4,6-triiodo-N- methylisophthalamic acid, there is obtained the desired 5- (3,3-dimethyll n-propylureido )-2,4,6triiodo-N-ethyl-N- methylisophthalamic acid.
EXAMPLE l2 5-( 3-n-Butylureido)-2,4,6-Triiodoisophthalamic Acid Following the procedure of Example 1 but substituting an equivalent amount 'of 5-amino-2,4,6-triiodoisophthalamic acid for the 5-amino-2,4,6-triiodo-N-methylisophthalamic acid and an equivalent amount of n-butyl isocyanate for the methyl isocyanate, there is obtained the desired 5-( B-n-butylureido)-2,4,6-triiodoisophthalamic acid.
EXAMPLE l3 5( 3 ,3-Dimethylureido)-2,4,6-Triiodoisophthalamic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-amino-2,4,6-triiodoisophthalamic acid for the 5-amino-2,4,6-triiodo-N-methylisophthalamic acid there is obtained the desired 5-(3,3-dimethylureido)- 2,4,6-triiodoisophthalamic acid.
EXAMPLE 14 a. 5-Ethylamino-2,4,6-Triiodoisophtha1amic Acid Following the procedure of Example 8 a,b, but substituting an equivalent amount of S-aminoisophthalamic acid for the 5- amino-N-methylisophthalamic acid and an equivalent amount EXAMPLE l5 5-( l,3,3-Triethylureido)-2,4,6-Triiodoisophthalamic Acid Following the procedure of Example 7 but substituting an equivalent amount of 5-ethylamino-2,4,6-triiodoisophthalamic acid for the 5-amino-2,4,6-triiodo-N-methyl-isophthalamic acid and an ealuivalent amount of dieth 'l-carbamoyl chloride ere is obtained the for the dime ylcarbamoyl chloride, desired 5-( l,3,3-triethylureido)-2,4,6-triiodoisophthalamic acid.
EXAMPLE l6 Ethyl 5-( 3-methylureido)-2,4,6-Triiodo-N-Methylisophthalamate To a stirred slurry of 21 grams of 5-( 3-methyl-ureido)-2,4,6 -triiodo-N-methylisophthalamic acid in ml of absolute ethanol, there is added a solution of '2.2 grams of potassium hydroxide in 50 m] of absolute ethanol. To this mixture there is added 4.5 ml of diethyl sulfate. The mixture is allowed to stir overnight and I00 ml of water added. The reaction mixture is concentrated to dryness and suspended in dilute alkali. The solution is filtered and the crude ester thus obtained is the desired ethyl 5-( 3-methylureido)-2,4,6-triiodo-N- methylisophthalamate. The product may be purified by solution in warm dimethylformamide, treating with decolorizing carbon and dilution of the filtrate with water to precipitate the desired ester.
What is claimed is:
l. A compound of the formula wherein R and R are hydrogen or alkyl of up to six carbon atoms and R is alkyl of up to six carbon atoms, as well as lower alkyl esters and physiologically acceptable salts thereof wherein the alkyl ester has up to six carbon atoms.
2. A compound of claim 1 wherein R and R are hydrogen.
3. A compound of claim 1 wherein R and R are alkyl.
4. A compound of claim 1 wherein R is hydrogen and R is alkyl.
5. A compound of claim 1 wherein R is alkyl and R is hydrogen.
Claims (4)
- 2. A compound of claim 1 wherein R and R2 are hydrogen.
- 3. A compound of claim 1 wherein R and R2 are alkyl.
- 4. A compound of claim 1 wherein R2 is hydrogen and R is alkyl.
- 5. A compound of claim 1 wherein R2 is alkyl and R is hydrogen.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4788670A | 1970-06-19 | 1970-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
US3666800A true US3666800A (en) | 1972-05-30 |
Family
ID=21951563
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US47886A Expired - Lifetime US3666800A (en) | 1970-06-19 | 1970-06-19 | Substituted triiodoisophthalamic acids |
Country Status (4)
Country | Link |
---|---|
US (1) | US3666800A (en) |
DE (1) | DE2129887A1 (en) |
FR (1) | FR2100792A1 (en) |
HU (1) | HU163043B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3914294A (en) * | 1972-06-01 | 1975-10-21 | Squibb & Sons Inc | 3,5-Disubstituted-2,4,6-triiodobenzoic acids |
US3953497A (en) * | 1974-07-29 | 1976-04-27 | Mallinckrodt, Inc. | 2,4,6-Triiodo-5-methoxyacetamido-N-methylisophthalamic acid and salts, acyl halides and esters thereof |
US4018783A (en) * | 1970-09-09 | 1977-04-19 | Beecham Group Limited | Esters of metrizoic acid |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003053100A1 (en) | 2001-12-15 | 2003-06-26 | Hermsdorfer Institut Für Technische Keramik E.V. | Electrical resistance heating element with a honeycomb body |
-
1970
- 1970-06-19 US US47886A patent/US3666800A/en not_active Expired - Lifetime
-
1971
- 1971-06-16 DE DE19712129887 patent/DE2129887A1/en active Pending
- 1971-06-18 FR FR7122293A patent/FR2100792A1/fr not_active Withdrawn
- 1971-06-18 HU HUSU634A patent/HU163043B/hu unknown
Non-Patent Citations (1)
Title |
---|
Fieser, L. F., et al. Organic Chemistry, 3rd Edit. (1956), pub. by Reinhold Pub. Corp. page. 608 cited. * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4018783A (en) * | 1970-09-09 | 1977-04-19 | Beecham Group Limited | Esters of metrizoic acid |
US3914294A (en) * | 1972-06-01 | 1975-10-21 | Squibb & Sons Inc | 3,5-Disubstituted-2,4,6-triiodobenzoic acids |
US3953497A (en) * | 1974-07-29 | 1976-04-27 | Mallinckrodt, Inc. | 2,4,6-Triiodo-5-methoxyacetamido-N-methylisophthalamic acid and salts, acyl halides and esters thereof |
Also Published As
Publication number | Publication date |
---|---|
DE2129887A1 (en) | 1973-07-12 |
HU163043B (en) | 1973-05-28 |
FR2100792A1 (en) | 1972-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2559942C2 (en) | Oxyimino-β-oxo-γ-halobutyric acid derivatives protected in the α-position and their use for the preparation of corresponding 2-amino-thiazol-4-yl-acetic acid derivatives | |
US3795698A (en) | Acetoxy methyl and pivaloyloxymethyl 5-acetamido-2,4,6-triiodo-n-methylisophthalamates | |
Wallingford et al. | X-Ray Contrast Media. I. Iodinated Acylaminobenzoic Acids1 | |
DE2508045A1 (en) | SUBSTITUTED N- (1-BENZYLPYRROLIDINYL-2-ALKYL) BENZAMIDES, METHOD FOR THE PREPARATION AND MEDICINAL PRODUCTS CONTAINING THESE | |
US2567651A (en) | J-dialkyl-g-amino-l | |
US3666800A (en) | Substituted triiodoisophthalamic acids | |
US3660464A (en) | Tri-iodinated diaminobenzoic acid derivatives | |
US2680133A (en) | Iodine-containing amino-benzoyl derivatives of amino acids | |
DE2454107A1 (en) | SUBSTITUTED UREA, ACYLURA AND SULFONYLURA DERIVATIVES AND PROCESS FOR THEIR PRODUCTION | |
DE1287081B (en) | Process for the preparation of N, N'-bis- (3-amino-5-carboxy-2, 4, 6-triiodophenyl) -alkanedicarboxamides or the corresponding carbonic acid diamides | |
IL23351A (en) | Benzenesulphonyl-ureas and process for the manufacture thereof | |
US3734953A (en) | Tris-triiodoisophthalamic acids and derivatives | |
CA1339665C (en) | Iodinated non-ionic triodobenzene compounds and contrast media containing them | |
US3210412A (en) | m-(alkanamidoalkanamido)-2, 4, 6-triiodobenzoic acid compounds | |
US3666799A (en) | Triiodated toluic acids | |
US2633466A (en) | Anhydro 2-carboxylicacylamino-3, 5-diiodobenzoic acids and process | |
US3819821A (en) | X-ray opacifiers | |
US3660469A (en) | Bis-triiodoisophthalamic acid compounds | |
US3721701A (en) | Radiopaque triiodoalkylureido benzoic acids | |
US2505634A (en) | 4-pyridone-nu-carboxylic acids | |
US3660466A (en) | 2 4 6-triiodobenzoic acid derivatives | |
US3769406A (en) | Treating hyperglycemia with phosphorylated guanidines and biguanidines | |
US2587936A (en) | Iodinated 2-acylamino benzoyl derivatives of amino acids | |
US2958692A (en) | S-carboxymethylmercapto-g- | |
DE970133C (en) | Process for the preparation of N-acyl derivatives of 3, 5-diamino-2, 4, 6-triiodo-benzoic acid |